Back to WA Waverly Advisors, LLC
CTSO
4 quarters
Position history for WAWaverly Advisors, LLC's holdings in Cytosorbents Corporation
No. Waverly Advisors exited its CTSO (Cytosorbents) position in Q2 2026. Its Q1 2026 13F listed 55,556 shares worth $31,461. Waverly Advisors first reported CTSO in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$51,895
Total Shares Change
-55,556
Quarter-by-Quarter History